AstraZeneca PLC Ordinary Shares (AZN)

Operating Cash Flow (Statement)

$13.81B

TTM · Period ending: · USD

AZN logo

AZN Operating Cash Flow (Statement)

Latest reported$13.81B
AZN TTM Cash from Operations ($3.43B → $13.81B)
High-resolution chart · PNG

AZN operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
13,810,311,611
14,309,041,994
14,663,041,994
15,140,000,000
13,389,000,000
13,088,000,000
11,861,000,000
11,334,000,000
11,065,000,000
9,698,000,000
10,345,000,000
10,363,000,000
10,179,000,000
9,709,000,000
9,808,000,000
8,828,000,000
7,617,000,000
7,261,000,000
5,963,000,000
6,343,000,000
6,446,000,000
6,594,000,000
4,799,000,000
4,376,000,000
3,657,000,000
3,495,000,000
2,969,000,000
3,818,000,000
3,184,000,000
2,371,000,000
2,618,000,000
1,391,000,000
3,165,000,000
3,350,000,000
3,578,000,000
4,541,000,000
3,109,000,000
3,040,000,000
4,145,000,000
2,756,000,000
3,690,000,000
4,589,000,000
3,324,000,000
4,595,000,000
4,800,000,000
5,799,000,000
7,058,000,000
7,694,000,000
6,862,000,000
6,389,000,000
7,400,000,000
7,770,000,000
7,961,000,000
7,606,000,000
6,948,000,000
7,169,000,000
7,783,000,000
7,471,000,000
7,821,000,000
8,312,000,000
8,742,000,000
10,831,000,000
10,680,000,000
11,202,000,000
11,172,000,000
11,251,000,000
11,739,000,000
10,448,000,000
9,784,000,000
8,578,000,000
8,742,000,000
8,949,000,000
8,618,000,000
7,714,000,000
7,510,000,000
6,672,000,000
7,456,000,000
8,368,000,000
7,693,000,000
7,462,000,000
7,010,000,000
6,746,000,000
6,743,000,000
5,856,000,000
5,612,000,000
5,100,000,000
4,873,000,000
4,102,000,000
3,733,169,703
3,534,085,117
3,415,999,998
3,925,923,690
3,819,191,574
4,088,959,078
4,832,999,998
4,663,732,836
4,732,887,306
4,265,764,993
3,600,767,189
3,092,818,616
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.